Compare ACA & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACA | XENE |
|---|---|---|
| Founded | 2018 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 5.9B |
| IPO Year | 2018 | 2014 |
| Metric | ACA | XENE |
|---|---|---|
| Price | $145.45 | $59.75 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 11 |
| Target Price | ★ $120.00 | $68.55 |
| AVG Volume (30 Days) | 526.4K | ★ 621.9K |
| Earning Date | 04-30-2026 | 05-08-2026 |
| Dividend Yield | ★ 0.17% | N/A |
| EPS Growth | ★ 121.99 | N/A |
| EPS | ★ 7.43 | N/A |
| Revenue | ★ $2,883,400,000.00 | $311,000.00 |
| Revenue This Year | $5.26 | N/A |
| Revenue Next Year | $6.49 | $2,496.48 |
| P/E Ratio | $19.59 | ★ N/A |
| Revenue Growth | ★ 12.20 | N/A |
| 52 Week Low | $89.09 | $35.60 |
| 52 Week High | $146.92 | $72.66 |
| Indicator | ACA | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 61.10 | 43.69 |
| Support Level | $144.54 | $52.40 |
| Resistance Level | $145.91 | $62.91 |
| Average True Range (ATR) | 0.29 | 2.20 |
| MACD | -0.11 | -0.22 |
| Stochastic Oscillator | 81.82 | 17.95 |
Arcosa Inc is a manufacturer and producer of infrastructure-related products and solutions in the U.S. It operates in three segments: Construction Products, Engineered Structures, and Transportation Products. Maximum revenue is generated from the Construction Products segment, which produces aggregates, specialty materials, asphalt, and construction support gear. The Engineered Structures segment mainly manufactures and sells steel and concrete structures for infrastructure businesses, including utility structures for electricity transmission and distribution, structural wind towers, traffic and lighting structures, and telecommunication structures; and the Transportation Products segment builds inland barges, fiberglass covers, winches, marine hardware, and other industrial equipment.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.